The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I–III breast cancer

Philip Poortmans(Instituut Verbeeten), Jack Venselaar(Instituut Verbeeten), H. Struikmans(University Medical Center Utrecht), Coen Hurkmans(The Netherlands Cancer Institute), J. Bernard Davis(University Hospital of Zurich), D. Huyskens(KU Leuven), Geertjan van Tienhoven(Academic Medical Center), V. Vlaun(Instituut Verbeeten), J J W Lagendijk(University Medical Center Utrecht), Ben J. Mijnheer(The Netherlands Cancer Institute), K.A De Winter(Instituut Verbeeten), Marleen H Van der Hulst(Instituut Verbeeten), Walter F.C Van den Bogaert(KU Leuven)
International Journal of Radiation Oncology*Biology*Physics
April 1, 2001
10.1016/s0360-3016(00)01549-2
Cited by 96

Abstract

Related Papers

No related papers found

Powered by citation graph analysis